KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to $8.7 million.

  • Exact Sciences' Gains from Investment Securities rose 6393.6% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year increase of 38531.22%. This contributed to the annual value of -$3.3 million for FY2024, which is 8145.64% up from last year.
  • Exact Sciences' Gains from Investment Securities amounted to $8.7 million in Q3 2025, which was up 6393.6% from $4.9 million recorded in Q2 2025.
  • Exact Sciences' 5-year Gains from Investment Securities high stood at $48.5 million for Q4 2021, and its period low was -$40.5 million during Q3 2021.
  • For the 5-year period, Exact Sciences' Gains from Investment Securities averaged around -$2.1 million, with its median value being -$9000.0 (2022).
  • In the last 5 years, Exact Sciences' Gains from Investment Securities soared by 80957.47% in 2021 and then crashed by 59830.34% in 2023.
  • Exact Sciences' Gains from Investment Securities (Quarter) stood at $48.5 million in 2021, then crashed by 97.94% to $1.0 million in 2022, then crashed by 598.3% to -$5.0 million in 2023, then soared by 79.57% to -$1.0 million in 2024, then surged by 953.43% to $8.7 million in 2025.
  • Its Gains from Investment Securities stands at $8.7 million for Q3 2025, versus $4.9 million for Q2 2025 and $8.3 million for Q1 2025.